Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis

American Journal of Clinical Pathology

Volumn 116, Issue 5, 2001, Pages 760-767

  Zhao, Dandan ^a   Ogawa, Hirokazu ^a   Wang, Xiang ^a   Cameron, Gregory S ^a   Baty, Darric E ^a   Dlott, Jeffrey S ^a   Triplett, Douglas A ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Anti oxLDL; Antiphospholipid syndrome; ELISA; Enzyme linked immunosorbent assay; Oxidized low density lipoprotein; oxLDL; Thrombosis

Indexed keywords

AUTOANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; THROMBOSIS;

EID: 0035736459     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/1RYQ-Q2AJ-CKF7-YCDE     Document Type: Article

References (44)

1. The anticardiolipin syndrome
2. Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance
3. Immunology of the antiphospholipid antibody syndrome
4. Stroke in systemic lupus erythematosus
5. Coronary arterial disease in systemic lupus erythematosus: Quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years
6. Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus
7. The oxidation hypothesis of atherosclerosis
8. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man
9. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein
10. The hyperlipoproteinemias and other disorders of lipid metabolism
11. Low density lipoprotein undergoes oxidative modification in vivo
12. Serum antibodies to oxidized low density lipoprotein and ceroid in chronic periaortitis
13. Autoantibody against oxidized LDL and progression of carotid atherosclerosis
14. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus
15. Rabbit and human atherosclerotic lesions contain IgG that recognizes MDA-LDL and copper-oxidized LDL
16. Direct evidence for a protein recognized by a monoclonal against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
17. Malonyldialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
18. Antiphospholipid antibodies and atherosclerosis
19. Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus
20. Syndrome of the black swan
21. Criteria for the diagnosis of lupus anticoagulants: An update
22. Practical methods for plasma lipoprotein analysis
23. Anticardiolipin antibodies in NZW x BXSB F1 mice: A model of antiphospholipid syndrome
24. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid and peroxyl radicals
25. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol
26. Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells
27. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes
28. Modified forms of low density lipoprotein affect platelet aggregation in vitro
29. Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL
30. Autoantibodies against oxidized low density lipoprotein (oxLDL): Characterisation of antibody isotype, subclass, affinity and effect on the macrophage uptake of ox-LDL
31. Antiphospholipid antibodies and myocardial infarction
32. Autoimmunity to oxidized lipoproteins
33. Antibody against low-density lipoprotein predicting myocardial infarction
34. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies
35. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: A unifying "membrane stress syndrome" hypothesis
36. Cardiac abnormalities in systemic lupus erythematosus: Association with raised anticardiolipin antibodies
37. Arterial disease in lupus and secondary antiphospholipid syndrome: Association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein
38. Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome
39. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates
40. Macrophage oxidation of low-density lipoprotein generates a modified form recognized by the scavenger receptor
41. Cofactor dependent and cofactor independent anticardiolipin antibodies
42. Antiphospholipid antibodies differ in aPL cofactor requirement
43. 2-glycoprotein 1 in patients withantiphospholipid syndrome